Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Classement en actions #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Prix de l'action
$25.28
Dernière synchronisation: 2026-09-18
Capitalisation boursière
$1.01B
Changement (1 jour)
-2.29%
Changement (1 an)
-37.84%
Pays
GB
Échange GSK plc (GSK)

Catégorie

EPS pour GSK plc (GSK)
EPS au June 2026 TTM : $3.27
Selon les derniers rapports financiers et le cours de l'action de GSK plc, l’EPS actuel de la société (TTM) est de $3.27. À la fin de 2024, la société avait un EPS de $1.58 une diminution par rapport à celui de 2023, qui était de $3.11.
Historique de l'EPS de GSK plc de 2000 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $3.27 -11.98%
2025 $3.71 134.74%
2024 $1.58 -49.10%
2023 $3.11 5.22%
2022 $2.95 -20.32%
2021 $3.70 -5.92%
2020 $3.94 26.89%
2019 $3.10 32.40%
2018 $2.34 122.33%
2017 $1.05 77.94%
2016 $0.59 -90.78%
2015 $6.42 186.38%
2014 $2.24 -51.96%
2013 $4.67 25.18%
2012 $3.73 -8.24%
2011 $4.07 226.52%
2010 $1.25 -71.71%
2009 $4.40 35.82%
2008 $3.24 -31.08%
2007 $4.70 0.76%
2006 $4.67 31.64%
2005 $3.55 8.50%
2004 $3.27 -5.77%
2003 $3.47 29.66%
2002 $2.67 45.99%
2001 $1.83 -27.83%
2000 $2.54 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$29.85 814.05%
US
$8.65 164.87%
US
$3.55 8.71%
US
$20.39 524.34%
CH
$1.26 -61.42%
US